A phase 2, proof-of-concept, placebo-controlled, randomized, multicenter, double-blind study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of Usnoflast (ZYIL1) in patients with amyotrophic lateral sclerosis.

Yeole A, Khanna L, Doshi M, Sharma A, Uttarwar P, Doshi S, Kaushik Kumar R, Venkataramana N, Parmar D

Small-molecule OPA1 inhibitors reverse mitochondrial adaptations to overcome therapy resistance in acute myeloid leukemia.

La Vecchia S, Doshi S, Antonoglou P, Kundu T, Al Santli W, Avrampou K, Witkowski MT, Pellattiero A, Magrin F, Ames K, Verma A, Gritsman K, Su X, Mattarei A, Aifantis I, Scorrano L, Glytsou C

Cancer Patient Perspectives on Clinical Trial Discussion and Informed Consent Through Telemedicine.

Khadem Charvadeh Y, Doshi SD, Seier K, Bange EM, Daly B, Lipitz-Snyderman A, Polubriaginof FCG, Buckley M, Kuperman G, Stetson PD, Schrag D, Morris MJ, Panageas KS

Correlation between serum bile acids with severity of liver cirrhosis: A case-control study.

Doshi S, Sonawane P, Agrawal U, Munshi AA

Secondary stroke evaluation in patients admitted for CRAO in a large national inpatient sample.

Doshi S, Bisen JB, Bains HK, Keshwani A, Cherayil N, Mirza RG

First-in-human study of a leadless pacemaker system for left bundle branch area pacing.

Reddy VY, Nair DG, Doshi SK, Doshi RN, Chovanec M, Ganz L, Sabet L, Jiang C, Neuzil P

A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma.

Kotecha RR, Doshi SD, Knezevic A, Jacobi R, Woo HJ, Aggen DH, McHugh DJ, Shah NJ, Carlo MI, Keegan NM, Gayadin Y, Chaim J, Donoghue MTA, Iyer G, Lee CH, Feldman DR, Motzer RJ, Voss MH

Primer part 2 - implementing a laboratory quality improvement project.

Bohn MK, Augustin R, Chartier LB, Devine L, Doshi S, Ginty L, Lass E, Leung F, Mundle W, Nimmo G, Sandy A, Shillington K, Simon A, Steiman A, Taher A, Friesner CT, Zanchetta C, Taher J

Mobiloblast - An Emerging Societal Menace.

Patil SB, Bhasin M, Gandhi A, Gupta N, Doshi S

Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation.

Kharbanda RK, Kennedy J, Jamal Z, Dodd M, Evans R, Bal KK, Perkins AD, Blackman DJ, Hildick-Smith D, Banning AP, Baumbach A, Ludman P, Palmer S, Stables RH, Henderson R, Appleby C, Cotton J, Curzen N, Ozkor M, Byrne J, Aggarwal R, Das R, Doshi S, Watkins S, Muir DF, Anderson R, Chowdhary S, Varcoe R, Dorman S, Firoozi S, Chelliah R, Owens C, Redwood S, Prendergast B, Iqbal J, Ratib K, Dospinescu C, Suresh V, Cruden N, Rajathurai T, Malik IS, Wiper A, Costopoulos C, Khurana A, Banning A, Clayton T, BHF PROTECT-TAVI Investigators